7S8-32289-32885
4 vaccinations
3 coded responses
35 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 462 / IN
- Registered
- 2021-01-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
AY8-31733-39522
Child or adolescent in my care · Male · 2022-06-28
LFN-93824-35013
Child or adolescent in my care · Male · 2022-06-28
Timeline
-
2021-01-02
Registered in v-safe
-
2021-01-02
Dose 1 — Moderna
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-16
- 2021-01-23
-
2021-01-30
Dose 2 — Moderna
- 2021-01-30
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Chills, Muscle or body achesAdult check-in
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-02-27
- 2021-03-06
- 2021-03-13
- 2021-05-01
- 2021-07-31
-
2021-08-31
Dose 3 — Pfizer-BioNTech
- 2021-11-30
- 2022-03-01
- 2022-08-31
-
2022-09-12
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-19
-
2022-09-26
Survey response — day 14, dose 4MedDRA: Chills, Cough, Fatigue, Myalgia, Oropharyngeal pain, Sinus congestion — Feeling: GoodFree text: Sinus congestion , myalgias, chills, sore throat, cough, fatigue.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-04
- 2022-10-10
- 2022-10-17
- 2022-10-24
-
2022-12-12
Survey response — 3 months, dose 4MedDRA: Viral upper respiratory tract infection — Feeling: GoodFree text: Viral upper respiratory infectionMedDRA releases: 2024-11 · check-in free text available
-
2023-03-13
Survey response — 6 months, dose 4MedDRA: Gastrointestinal disorder, Respiratory tract infection viral — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-02 | Moderna | |
| 2 | 2021-01-30 | Moderna | |
| 3 | 2021-08-31 | Pfizer-BioNTech | No |
| 4 | 2022-09-12 | Pfizer-BioNTech | Flu |
Free text
Release 12 — day 14, dose 4
Symptoms: Sinus congestion , myalgias, chills, sore throat, cough, fatigue.
Release 12 — 3 months, dose 4
Symptoms: Viral upper respiratory infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract infection viral | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Viral upper respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release